Loading...
Developing Drugs for Tissue‐Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine
Targeted therapies have reshaped the landscape of the development of cancer therapeutics. Recent biomarker‐driven, tissue‐agnostic clinical trials represent a significant paradigm shift in precision cancer medicine. Despite their growth in preclinical and clinical studies, to date only a few biomark...
Na minha lista:
| Udgivet i: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7891377/ https://ncbi.nlm.nih.gov/pubmed/32535906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1946 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|